Latest radiopharmaceuticals Stories
Opportunities for developments, mergers and acquisitions, and investments are just ahead. Louvain-la-Neuve, Belgium, and Lalaye, France (PRWEB) March 13, 2014
SAINT-GENIS-POUILLY, France, March 4, 2014 /PRNewswire/ -- Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM),
Nuclear Medicine / Radiopharmaceuticals Market report broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012 and forecast to 2017.
Mount Sinai Heart leads international research team testing new sugar-based tracer to help in the cardiovascular imaging hunt for inflamed high-risk, vulnerable artery plaques before they rupture.
DUBLIN, January 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tz54gw/european_nuclear) has announced the addition of the "European
DUBLIN, January 3, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2q5v4f/radiopharmaceutica) has announced the addition of the "Global
DUBLIN, December 27, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tn88ln/nuclear_medicine) has announced the addition of the "Global
RadioMedix Inc. (Houston, TX) received the exclusive authorization for the U.S. distribution of the 68Ge/68Ge generators produced by ITG Isotope Technologies Garching GmbH (Germany).
Nuclear Medicine Market & Radiopharmaceuticals Market report covers competitive landscape and key developments of major players, pipeline analysis, investment opportunities, and regulatory
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.